A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
Neurons mature and acquire their firing properties with the help of Rbfox genes, a family of genes linked to autism and other neurodevelopmental disorders.
